Aktien

Montea secures 95% of €1.15 bln Track27 plan, leasing volume hits 255k sqm
Belgian logistics REIT reports H1 2026 EPRA EPS up 5% YoY, portfolio occupancy at 99.4% and Track27 investment pipeline 95% funded.

Gray Media refinances $750 mln debt at 7.5% to cut costs
Media group issues senior secured notes due 2034 to refinance higher-cost 2029 debt and reduce revolving credit exposure. Proceeds total $750 million.

Arena REIT posts 8% FY2026 profit growth as Edge tenant default risk lingers
Australia’s Arena REIT reported an 8% rise in net operating profit to $79 million for FY2026, but warned of tenant risk after Edge Early Learning defaulted on rent. The childcare operator’s 31 properties account for 14% of Arena’s rental income.

US stocks set for weekly lows as Walmart drags; Swiss market extends losses
Walmart shares slump 6% in pre-market after weak U.S. sales, dragging retail peers lower. SMI extends declines as Logitech and Swiss Re lead losers; oil hits four-week high.

German DAX falls below 26,000 points amid energy and rate pressures
The German blue-chip index slipped 0.65% to 25,921 points, extending losses as rising oil prices and bond yields weighed on sentiment. The Euro Stoxx 50 and MDax also declined.

Volkswagen CEO flags 'critical' outlook, warns of deeper cost cuts
Blume says operating margin of 3.8% is insufficient for long-term investments, as group prepares to unveil sharper austerity plan by year-end.

Barclays upgrades 10 European diversified financials stocks on earnings momentum
Analysts flag 3i Group, Deutsche Boerse and Partners Group among ten names in the sector, citing earnings revisions as the primary driver of returns. Weakness at OneSavings Bank and Avanza Bank noted.

NIBE Industrier shares rise on strong Q2 earnings, heat pump demand
Swedish heat pump maker NIBE Industrier advanced after reporting a 9% operating margin in Q1 2026 and citing a 49% surge in German heat pump subsidy applications.

European metals stocks poised for gains if U.S.-Canada tariffs halve
Morgan Stanley analysis projects ArcelorMittal as the top beneficiary, with potential annualized pre-tax relief of $300-$350 million. Rio Tinto, SSAB and Norsk Hydro face mixed impacts.

Harrow’s eye anesthesia gel shows 58% less discomfort in study
IHEEZO gel outperformed proparacaine in a 50-patient trial, with statistically significant reductions in pain across all post-injection time points.

IntraGel raises $7M from UroGen for head and neck cancer therapy
Funds will advance TumoCure through Phase 2 trials after Phase 1b data showed safety and early efficacy. UroGen gains exclusive global rights option under the deal.

Aryzta shares drop 6% after UBS downgrades to sell on margin concerns
Swiss bakery group’s stock falls as UBS cuts price target to CHF40 and slashes earnings forecasts, citing weaker growth and margin pressures in Germany and GLP-1 diet trends.

US equities mixed; SMI edges lower as oil hits four-week high
Futures on the Dow slipped 0.13% while Nasdaq futures rose 0.1% ahead of U.S. open. Brent crude surged 2.6% to $94.04/bbl, nearing $100/bbl. Swiss Re and Logitech led SMI laggards.

LSI Industries CFO to retire in August 2027 after decade-long tenure
James E. Galeese, CFO since 2017, will step down after over 10 years with the Cincinnati-based lighting and display manufacturer. The company plans to name a successor by mid-2027.

D.E. Shaw discloses $1B+ stake in Sysco amid AI push
Hedge fund D.E. Shaw reveals a more than $1 billion stake in Sysco, as the food distributor accelerates AI-driven efficiency gains and eyes a major acquisition. Sysco’s stock has underperformed over the past year.

Michelin shares rise 1.7% after JPMorgan upgrade to Overweight
Stock climbs to €34.68 as JPMorgan lifts price target to €42, citing accelerating truck tire demand and durable growth in high-tech composites.

Ultragenyx surges 11% after FDA approval of gene therapy for rare disease
Ultragenyx shares jumped 11.1% in pre-market trading after the FDA granted accelerated approval for GENGLYCOS, the company's first gene therapy. Analysts raised price targets to as high as $58.

Target’s grocery push drives traffic growth, but broader shopper appeal remains key
Food and beverage sales rose 7% in the latest quarter as Target expands private-label offerings, yet grocery still accounts for less than a quarter of total merchandise sales.
Robo.ai to release H1 2026 results Sunday after restructuring
The Abu Dhabi-based AI firm will file unaudited financials with the SEC on Sunday, following the disposal of legacy operations and acquisition of Neurovia AI and Quantum Core Capital.

Hays profit rises 3% in FY26 as £50m cost cuts offset fee decline
Pre-exceptional operating profit increased to £48.6m despite an 8% drop in net fees to £905.5m, as restructuring delivered £50m in annualized savings ahead of schedule.

Swiss Prime Site posts 5.1% EPS growth, portfolio value tops CHF 14bn
H1 2026 results show funds from operations per share at CHF 2.15, with full-year guidance raised to the upper end of CHF 4.25-4.30. Asset management AuM rose to CHF 14.8bn.

Swiss Market Index slips 0.26% as Logitech, Swiss Re lead declines
Logitech and Swiss Re shares drop nearly 3% each as SMI falls 0.26%, while Aryzta hits multi-year low after UBS downgrade. Oil near $94, Brent nears $100 as inflation concerns resurface.

Euro Stoxx 50 falls as yields, oil rise; Swiss SMI supported by China trade deal
Eurozone blue-chip index down 0.35% as bond yields climb and crude oil advances; Swiss SMI pares losses to 0.13% on China trade pact. JD Sports drops 14% on weak outlook; Eni, BP gain on higher oil.

Basilea shares hit eight-year high after strong H1 results
Swiss biopharma firm’s stock surges 3% to CHF 64.30 as first-half revenue beats expectations, driven by Cresemba’s global uptake. Patent cliff looms from late 2027.

